Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00040339 · ClinicalTrials.gov registry record · NA
Hypothermia to Treat Severe Brain Injury
A NA study of Brain Injuries and Hypothermia, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
- 5
- Study locations
NCT00040339: Completed NA study of Brain Injuries and Hypothermia, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
NCT00040339 is a NA study of Brain Injuries and Hypothermia that has completed, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 42 participants, below the 329-participant average among 22 other Brain Injuries trials with a reported enrollment target (87% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00040339, a NA study of Brain Injuries and Hypothermia, has completed, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this trial is to determine if hypothermia (body cooling), administered very soon after a severe brain injury improves functional outcome. This pilot trial ended in July 2005. Please see clinicaltrials.gov record number NCT00178711 for the Phase III version of the trial (see link below).
Conditions Studied
Interventions
- PROCEDURE hypothermia (body temperature lowered to 33°C or 91.4°F)
Study Locations (5)
Missouri
- St. Louis University - St Louis
Ohio
- University of Cincinnati - Cincinnati
Pennsylvania
- University of Pittsburgh - Pittsburgh
Texas
- University of Texas-Houston - Houston
Alberta
- University of Calgary - Calgary
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2002-05 |
| Est. Completion | 2005-07 |
| Phase | NA |
What the finished NCT00040339 record still lists
NCT00040339 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 329-participant average among 22 other Brain Injuries trials with a reported enrollment target (87% lower).
The record links to 2 conditions, with Brain Injuries appearing as the primary indexed condition, and to 1 intervention - of which hypothermia (body temperature lowered to 33°C or 91.4°F) is the first listed.
NCT00040339 lists 5 locations in 5 states (Missouri, Ohio, Pennsylvania).
Frequently Asked Questions
What is clinical trial NCT00040339 about?
NCT00040339 is a clinical study titled "Hypothermia to Treat Severe Brain Injury". The purpose of this trial is to determine if hypothermia (body cooling), administered very soon after a severe brain injury improves functional outcome. This pilot trial ended in July 2005. Please see clinicaltrials.gov record number NCT00178711 for the Phase III version of the trial (see link below...
What is the current status of trial NCT00040339?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2002-05. Estimated completion is 2005-07.
What conditions does trial NCT00040339 study?
This clinical trial studies the following conditions: Brain Injuries, Hypothermia.
What interventions are being tested in trial NCT00040339?
The interventions under investigation include: hypothermia (body temperature lowered to 33°C or 91.4°F) (PROCEDURE).
Who is sponsoring clinical trial NCT00040339?
This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00040339 being conducted?
This trial has 5 study locations across Missouri, Ohio, Pennsylvania, Texas, Alberta. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00040339's enrollment target sits among peer trials
42 17th of 22 higher than 6 of 22 other Brain Injuries trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Brain Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Remotely Supervised tDCS+ for Complex Attention in mTBI (Cognetric)
RECRUITING · NA
-
The Gut-Brain Axis During Neurorehabilitation; Prebiotic Treatment to Alter the Gut Microbiome and Neurologic Symptoms
RECRUITING · NA
-
Biomarker Role in Assessing Imaging Needs for Mild Cranial Trauma
RECRUITING · NA
-
Mobile Health Self-Management and Support System for Chronic and Complex Health Conditions
RECRUITING · NA
-
The HOME Study (Healthy Options Made Easy): Telehealth Nutrition Sessions for People Living With Brain Injury
RECRUITING · NA
-
Animal Assisted Therapy After Pediatric Brain Injury: Mediators and Moderators of Treatment Response.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia